Phillip G. Febbo, Chief Scientific & Med Officer at VERACYTE, INC. (VCYT), sold 16,698 shares at $36.02 ($601K) on 2025-10-06, disclosed to the SEC on 2025-10-07.
Scheduled sale ($601k) by Chief Scientific & Med Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $36.02 | 8,349 | $301K | 50.0% |
| 2 | $36.02 | 8,349 | $301K | 50.0% |
| Total | $36.02 avg | 16,698 | $601K | 100% |
| Filing → |
| VCYT | SELL | 2025-03-06 | $536K | — | Filing → |
| VCYT | SELL | 2024-12-06 | $347K | — | Filing → |
| ILMN | SELL | 2022-04-07 | $1.4M | — | Filing → |